Pfizer's drug for advanced lung cancer shows promising long-term trial results
Publishing timestamp: 2024-05-31 13:46:15
Summary
Pfizer's drug for advanced lung cancer showed promising long-term results in a late-stage trial, potentially establishing it as a new standard treatment. The drug, Lorbrena, helped patients live longer without cancer progression, with most experiencing benefits for over five years. The data will be presented at the American Society of Clinical Oncology's annual meeting in Chicago.
Sentiment: POSITIVE
Tickers: PFE,
Keywords: business news, pfizer inc, biotech and pharmaceuticals, breaking news, science, biotechnology, pharmaceuticals, health care industry, business,
Source: https://www.cnbc.com/2024/05/31/pfizer-lung-cancer-drug-shows-promising-long-term-trial-results.html